Pipeline Preview


Nelarabine (Arranon, GlaxoSmithKline) injection for the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in pediatric and adult patients whose disease has not responded to or has relapsed following treatment with at least 2 chemotherapy regimens.

Recommendations for accelerated approval

Recommendations for approval

Orphan drug designations

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.